Integrative epigenetic taxonomy of primary prostate cancer

Autor: Andries M. Bergman, Eider Valle-Encinas, Seiwon Laura Chang, Karianne Schuurman, João Lobo, Rui Henrique, Felix Y. Feng, Carmen Jerónimo, Suzan Stelloo, Wilbert Zwart, Ekaterina Nevedomskaya, Oscar Krijgsman, Daniel S. Peeper, L. F. A. Wessels, Yongsoo Kim
Přispěvatelé: Pathology, Internal medicine, Institute for Complex Molecular Systems, Chemical Biology
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Epigenomics
Male
Androgen/metabolism
Science
Histones/metabolism
General Physics and Astronomy
Receptors
Androgen/metabolism

Biology
SDG 3 – Goede gezondheid en welzijn
General Biochemistry
Genetics and Molecular Biology

Article
Carcinoma/metabolism
Epigenesis
Genetic

Histones
03 medical and health sciences
Prostate cancer
Genetic
SDG 3 - Good Health and Well-being
Receptors
medicine
Humans
Epigenetics
lcsh:Science
Aged
Regulation of gene expression
Multidisciplinary
Sequence Analysis
RNA

Chromatin binding
Carcinoma
Wnt signaling pathway
Prostatic Neoplasms
General Chemistry
Middle Aged
Prostatic Neoplasms/metabolism
medicine.disease
3. Good health
Androgen receptor
Molecular Typing
030104 developmental biology
Receptors
Androgen

Cancer research
H3K4me3
RNA
lcsh:Q
Sequence Analysis
Epigenesis
Zdroj: Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Nature Communications, 9(1):4900. Nature Publishing Group UK
Nature Communications, 9(1)
Nature Communications, 9(1):4900. Nature Publishing Group
Nature Communications
Stelloo, S, Nevedomskaya, E, Kim, Y, Schuurman, K, Valle-Encinas, E, Lobo, J, Krijgsman, O, Peeper, D S, Chang, S L, Feng, F Y C, Wessels, L F A, Henrique, R, Jerónimo, C, Bergman, A M & Zwart, W 2018, ' Integrative epigenetic taxonomy of primary prostate cancer ', Nature Communications, vol. 9, no. 1, 4900 . https://doi.org/10.1038/s41467-018-07270-2
ISSN: 2041-1723
DOI: 10.1038/s41467-018-07270-2
Popis: The Androgen Receptor (AR) is the key-driving transcription factor in prostate cancer, tightly controlled by epigenetic regulation. To date, most epigenetic profiling has been performed in cell lines or limited tissue samples. Here, to comprehensively study the epigenetic landscape, we perform RNA-seq with ChIP-seq for AR and histone modification marks (H3K27ac, H3K4me3, H3K27me3) in 100 primary prostate carcinomas. Integrative molecular subtyping of the five data streams revealed three major subtypes of which two were clearly TMPRSS2-ERG dictated. Importantly, we identify a third subtype with low chromatin binding and activity of AR, but with high activity of FGF and WNT signaling. While positive for neuroendocrine-hallmark genes, these tumors were copy number-neutral with low mutational burden, significantly depleted for genes characteristic of poor-outcome associated luminal B-subtype. We present a unique resource on transcriptional and epigenetic control in prostate cancer, revealing tight control of gene regulation differentially dictated by AR over three subtypes.
The Androgen Receptor (AR) is the main driver of prostate cancer and functions in conjunction with chromatin modifications. Here, the authors comprehensively profile 100 primary prostate carcinomas by sequencing RNA transcripts in combination with ChIP-sequencing for AR and the active histone marks H3K27ac, H3K4me3 and repressive mark H3K27me3.
Databáze: OpenAIRE